| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |